Review Article | Open Access
Hua-Xiao Yang, Min Sun, Yi Zhang, Ping Zhou, "Degradable PHBHHx Modified by the Silk Fibroin for the Applications of Cardiovascular Tissue Engineering", International Scholarly Research Notices, vol. 2011, Article ID 389872, 11 pages, 2011. https://doi.org/10.5402/2011/389872
Degradable PHBHHx Modified by the Silk Fibroin for the Applications of Cardiovascular Tissue Engineering
Biodegradable polymer, poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx), has been used to fabricate the tissue-engineered cardiovascular scaffolds due to its controllable and suitable mechanical properties. However, the unsound biocompatibility of PHBHHx is still the unsolved problem till now. Silk fibroin (SF) with low inflammation, no blood clotting, and good cell and tissue compatibility in vitro and vivo is adopted as a surface modificator to improve the biocompatibility of PHBHHx. The adhesion of SF on PHBHHx surface was investigated by infrared spectroscopy and water contact angle. The proliferation and morphologies of human fibroblasts, human smooth muscle cells, endothelial-like cell line ECV304, and umbilical vein endothelial cells on the SF-modified PHBHHx were studied by the assays of MTT, H&E staining, DAPI staining, and the scanning electron microscopy. In sum, SF-modified PHBHHx scaffolds are highly biocompatible with cardiovascular-related cells, demonstrating its potential help for the extensive applications of PHBHHx in the cardiovascular regeneration.
In the field of cardiovascular disease, more than 100,000 patients in USA every year need to have their dysfunctional or diseased valves replaced with the prosthetic valves . The traditional artificial heart valves are made from inert metals or nondegradable polymers to maintain the basic physiological functions. These types of artificial heart valves have the tendency to produce thrombus and have to be renewed several years after implantation, therefore, cannot be regarded as an ultimate replacement for patients, especially for infants or children. Considering the patient compliance, many researchers have attempted to find an alternate material that is capable of biomimicking the extracellular matrix (ECM) for cell attaching, proliferating, differentiating, and immigrating .
Biodegradable polymers, such as poly(L-lactide-co-glycolide) (PLGA), poly(ε-caprolactone) (PCL), and polyhydroxyalkanoates (PHAs), have been widely investigated during recent decades [3–6] for the tissue-engineering application. Among these polymers, PHAs family (such as PHB, PHBV) is well known for its low toxicity as well as therapeutic or nutritional benefits to cells . In addition, as a degradation product from PHAs, hydroxyl butyrate (HB) is a normal metabolized component in the blood circulation system. It has also been found that HB can promote the L929 cells proliferating in vitro . Among PHAs family, PHBHHx is a new member, copolymer of hydroxyl butyrate (HB), and hydroxyl hexanoate (HH), which is synthesized by the microorganism . The “x” in PHBHHx represents the content of hydroxyl hexanoate. The proper content of hydroxyl hexanoate ensures PHBHHx have low crystallinity, resulting in a higher tensile strength and strain of PHBHHx than that of PHB [3, 9, 10], therefore, the adjustable molecular weight and composition ratio enable the PHBHHx to meet the requirements of various tissue-engineered organs , such as tissue-engineered heart valve  and bone . Therefore, PHBHHx has become one of promising candidates for tissue-engineering material. Qu et al. transplanted the PHBHHx, PLA, and PHB films into the back of New Zealand white rabbits. It was found that PHBHHx showed a very mild tissue response during 6-month test, compared to other two films . However, many biodegradable polymers usually have high hydrophobicity and lack of the recognition domains for the cells. Therefore, people have tried to improve the polymer hydrophilicity by various methods. Ho et al. mobilized the RGD peptides on the PLLA membrane to improve its biocompatibility . To improve the affinity of fibroblasts, Wang et al. introduced the functional hydrophilic chemical groups, such as –NH2 and –OH, by treating the polymer surface with plasma technique. Silk fibroin (SF) from cocoon of silkworm has been demonstrated to have the ability of anti-blood clotting  and less inflammation reactions to the macrophage , therefore, it has been attended recently. During past years, natural silk fibroin has been used in our laboratory to modify the surface of PHBHHx (HHx = 12 mol%) and attempted to make the cardiovascular cells, fibroblasts, smooth muscle cells (SMCs), and endothelial cells (ECs) proliferate well on the polymer surface [6, 17–19]. We have demonstrated that PHBHHx scaffolds modified by the silk fibroin not only have the good mechanical properties of the synthetic polymer, but also have the excellent biocompatibility of the natural biomacromolecules. In this review, we would like to introduce some of research results about our work.
2. Properties of PHBHHx
2.1. Mechanic Property of PHBHHx
The cardiovascular tissue engineering requires the material having high tensile strength and strain to bear the dilatation. Therefore, it is important to have comparable mechanical properties of material with target tissue. Zhao et al. transplanted the PHB scaffold into a lamb for 20 weeks and found that the mechanical properties of the PHB-made new tissue resembled those of the native valve tissue . The mechanical strength of PHBHHx (HHx = 12 mol%) and silk fibroin-modified PHBHHx (HHx = 12 mol%) has been investigated in the previous work in our laboratory . The results are shown in Figure 1. It can be concluded from Figure 1 that the stress-stain curve of SF-modified PHBHHx (Figure 1(a)) and PHBHHx (Figure 1(b)) films is in similar shape, which is the typical pattern of the plastic material. The SF-modified PHBHHx films have the maximum tensile strength of MPa and the elongation at break of %, slightly lower than that of PHBHHx film, which is MPa and %, respectively. The small decrease in the elongation of SF-modified PHBHHx film might result from the addition of silk fibroin in the PHBHHx film which is swelled by the water/acetone solution during the process of modification . The native cardiovascular tissue has yield strength of about 0.7~8 MPa and a maximum elongation of 150% . Therefore, SF-modified PHBHHx material is a potential material applicable in the cardiovascular tissue engineering because of its proper mechanical properties.
2.2. Water Diffusion in PHBHHx
When biodegradable PHBHHx is used to construct a scaffold and implanted into the body, nutrition transportation is an important issue. Water diffusion ability in the scaffold plays a key role in the transportation process. Water diffusion is affected by many factors, such as polymer categories, crystalline degree. We used time-resolved attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) to investigate the process of water diffusion in the PHBHHx (HHx = 12 mol%) matrix with crystalline degree of % .
Time-resolved ATR-FTIR is a powerful technique for the measurement of small molecule diffusion in situ in the polymer . Figure 2 is ATR-FTIR spectra of the PHBHHx film as water diffusion and shows the increased absorbance during water diffusion. Here, the stretching and bending bands of –OH of water molecules are utilized to evaluate the water diffusion coefficient. The experimental data from the integrals of (OH) stretching band at 3700~3000 cm−1 (Figure 3(a)) and (OH) bending band at 1700~1550 cm−1 (Figure 3(b)) versus diffusion time and the exponentially stimulated curves are shown in Figure 3. Two parallel samples, Sample I and II, of the PHBHHx films were measured for the average result.
From Figure 3, the water diffusion coefficient of cm2 s−1 in the PHBHHx is deduced. Compared with the water diffusion coefficient of cm2 s−1 in PHB [22, 23], the larger water diffusion coefficient of PHBHHx than that of PHB indicates that PHBHHx is more to the tissue-engineering materials, especially to the transportation of water and the water-soluble nutrition into the cells through the polymer scaffold.
3. Properties of Silk Fibroin on the PHBHHx Surface
3.1. Adhesion Ability of Silk Fibroin on the PHBHHx Surface
0.75 wt% silk fibroin solution was used to modify the porous PHBHHx scaffold [19, 20]. The results were characterized by ATR-FTIR which can noninvasively detect the chemical groups on the surface of the film.
ATR-FTIR analysis is performed to examine the presence of the silk fibroin on the surface of SF-modified PHBHHx porous scaffold as well as the behavior of silk fibroin conformation. The bands of Amide I and Amide II in infrared (IR) spectrum are very useful for the conformational analysis of the protein. In general, the Amide I mode of silk fibroin associating with the -form conformation appears at 1650–1660 cm−1, whereas the random coil conformation at 1640–1650 cm−1 and the -form conformation at 1620 and 1640 cm−1; the Amide II mode of silk fibroin appear at 1520–1530 cm−1.
Figure 4 represents the ATR-FTIR spectra of PHBHHx porous scaffold (Figure 4(A)), SF-modified scaffold without (Figure 4(B)) and with (Figure 4(C)) methanol treatment, respectively. It can be observed that there are some peculiar peaks, 1653, 1622, and 1526 cm−1 appear in both spectra of Figures 4(B) and 4(C) when compared with Figure 4(A), which demonstrates the presence of silk fibroin on the surfaces of SF-modified PHBHHx scaffolds as have been proved in a film by Cai et al. . Notably, the peak at 1653 cm−1 (Figure 4(B)) indicates that the silk fibroin conformation is -form before the scaffold is treated by methanol. However, the silk fibroin conformation transition from water-soluble -form to water-insoluble -form happens after methanol treatment, which is evidenced by the Amide I peak shifted from 1653 cm−1 (Figure 4(B)) to 1622 cm−1 (Figure 4(C)), resulting in the immobilization of the silk fibroin on the scaffolds . Therefore, to prevent the dissolution of the coated silk fibroin from the scaffolds in our experimental conditions, all the SF-modified scaffolds are treated by methanol.
If the SF-modified PHBHHx scaffold were applied into the cardiovascular tissue engineering, it would bear the high sheer-stress of blood flow in the blood vessel, so a firm adhesion of SF on the surface of scaffold is required. We tested the ability of silk fibroin adhered on the PHBHHx surface under a physiologically flushed condition by phosphate buffer saline (PBS, pH = 7.4) solution. Here, ATR-FTIR was used to detect the presence of silk fibroin on the surface of SF-modified PHBHHx porous scaffold before and after flushed with PBS solution for different periods of flushed time. Since the low concentration of SF solution could penetrate through the SF-modified PHBHHx scaffold, it was considered that the SF could be absorbed not only on the surface of porous scaffold, but also in the scaffold pores. Figure 5(a) is the ATR-FTIR spectrum of PHBHHx scaffold and Figures 5(b)–5(e) show the spectra of SF-modified PHBHHx scaffolds flushed for 0, 7, 14, and 21 days, respectively. The peak assignments of FTIR spectrum of PHBHHx and SF/PHBHHx samples are summarized in Table 1.
Compared with the peaks in the spectrum of PHBHHx scaffold (Figure 5(a)), the peaks at 1652 cm−1 and 1540 cm−1 from silk fibroin [19, 25] are found in the spectra of SF-modified PHBHHx (SF/PHBHHx) scaffolds (Figures 5(b)–5(e)). It demonstrates that silk fibroin was successfully absorbed on the porous scaffold, even the scaffolds were flushed by PBS solution for 21 days. It was also found that for the PHBHHx scaffold, the C=O peak at 1723 cm−1 decreases gradually while the new peaks at 1600 cm−1 and 1413 cm−1 increase after being flushed for 21 days, demonstrating the partial hydrolysis of the PHBHHx. Meanwhile, the peak at 1230 cm−1 decreases, which indicates the helical conformation of PHBHHx changes . The intensity of peak at 1460 cm−1 in PHBHHx scaffold slightly increases during flushing process, indicating the presence of hydrolyzed products in the scaffold. The repeated experiments herein prove that the peak at 1460 cm−1 is much stronger in the flushed SF/PHBHHx scaffold than that in the SF/PHBHHx scaffold, perhaps due to PBS solution changing the polar environment of CH3 group . Conclusively, we think that the silk fibroin anchors on the scaffold by the hydrogen bonding interaction with PHBHHx , even when the PHBHHx is partially hydrolyzed in the mimic flowing blood system.
3.2. Hydrophilic Property of Silk Fibroin-Modified PHBHHx
The water contact angle of material surface can be used to characterize the hydrophilicity of SF-modified PHBHHx. It is found in Figure 6 that the static water contact angle of PHBHHx film decreases from 90° to 52° after PHBHHx film is modified by silk fibroin, which demonstrates that the silk fibroin considerably affects the surface wettability of the scaffold, making the scaffold more hydrophilic.
Moreover, based on the measurement of H2O and CH2I2 contact angles on the material surface, the surface free energy of PHBHHx and SF-modified PHBHHx can be calculated according to the following equations: where and are the total surface energies of H2O and CH2I2 on the material surface, respectively; represents the dispersive components, represents the polar components; is contact angle of H2O; is contact angle of CH2I2. For H2O, mJ/m2, mJ/m2, mJ/m2. For CH2I2, mJ/m2, mJ/m2, mJ/m2. The total surface free energy () is sum of dispersive () and polar () components. The calculated surface free energies of PHBHHx and SF-modified PHBHHx are summarized in Table 2. It can be found that the of SF-modified PHBHHx film is larger than that of unmodified PHBHHx film due to the larger polar component () of the SF-modified PHBHHx, demonstrating that the silk fibroin can make the PHBHHx more polar and hydrophilic.
As we know, cells favor the appropriately hydrophilic interface of scaffold for the growth and proliferation , the role of the silk fibroin does increase the hydrophilic property of the PHBHHx.
4. Biocompatibility of Silk Fibroin-Modified PHBHHx
The heart valve and blood vessel are composed by three important cells, fibroblasts, smooth muscle cells, and endothelial cells (ECs) as well  and [19, 25, 28]. The biocompatibility of human fibroblasts, human smooth muscle cells (hSMCs), and human umbilical vein endothelial cells (HUVECs) on the PHBHHx and SF-modified PHBHHx scaffolds were investigated.
4.1. Human Fibroblasts on the Silk Fibroin-Modified PHBHHx
4.1.1. Cells Vitality
The vitality of the fibroblasts cultured on the scaffolds is tested by MTT assay. MTT is the abbreviation of 3-(4,5-dimethylthiazol-2-yl)-diphenyltetrazolium bromide, which is a rapid colorimetric method to determine the viable cell numbers based on the mitochondrial conversion of the tetrazolium to MTT formazan. The higher optical density (OD) value of MTT indicates the more live cells on the scaffold. Figure 7 show the OD values of the fibroblasts cultured on the PHBHHx and SF-modified PHBHHx porous scaffolds for different days. It showed that the OD values are higher on the SF-modified PHBHHx scaffold than that on the unmodified ones cultured from 1 to 21 days.
4.1.2. Cells Morphology
The morphologies of the fibroblasts cultured on SF-modified PHBHHx porous scaffold in different culture days are observed by SEM images shown in Figure 8. It shows that the shapes of the cells on the unmodified (Figure 8(a)) and modified scaffolds (Figure 8(b)) look like sphere after one day of culture. After three days of culture, the cells elongate with shuttle-like shape (Figure 8(c)). After seven days of culture, the cells grow into confluence on the surface (Figure 8(d)) and in the pores (Figure 8(e)) of SF-modified PHBHHx porous scaffolds.
As above, both of MTT assay and SEM observation prove the outstanding biocompatibility of the SF-modified PHBHHx porous scaffold for the fibroblasts cultured in vitro. Fibroblasts grow and proliferate better on modified scaffold than unmodified ones, and reach confluence on the surface of modified scaffold after 7 days of culture.
4.2. Human Smooth Muscle Cells on the Silk Fibroin-Modified PHBHHx
4.2.1. Cells Vitality
The results of MTT assay for the human smooth muscle cells (hSMCs) on the porous scaffolds are shown in Figure 9. It can be found that the SF-modified PHBHHx porous scaffolds have obvious advantage for supporting the hSMCs growth and proliferation in the culture days between 3 to 21 days. In particular, in two weeks culture, the hSMCs on the unmodified scaffold nearly cease proliferating while they continue proliferating on the SF-modified scaffold.
4.2.2. Cells Morphology
The morphologies of hSMCs cultured in silk fibroin-modified porous PHBHHx scaffold are also observed by SEM as shown in Figure 10. From 1 to 7 days of culture, hSMCs show the round cells after 1 day of culture (Figure 10(a)), and then the cells stretch out as the pseudopodia (see inserted illustration in Figure 10(b)) after 3 days culture, and some cells migrate into the pores (Figure 10(c)) and form the cell monolayer on the surface of scaffolds in 7 days of culture (Figure 10(d)).
The SF-modified PHBHHx porous scaffold is verified to better support the hSMCs growth and proliferation than the unmodified one, evaluated by the methods of MTT assay and SEM observation.
4.3. Human Umbilical Vein Endothelial Cells and ECV304 on the Silk Fibroin-Modified PHBHHx
Endothelial cells as a component of inner surface in the blood vessel directly contact with the blood and functionalize as an anti-blood clotting layer. Herein, human umbilical vein endothelial cells (HUVECs) are isolated from the human umbilical vein. The ECV304 is a kind of endothelial-like cell line.
4.3.1. Cells Vitality
Figure 11 shows the results of MTT assay of HUVECs and ECV304 cultured on the porous PHBHHx scaffold. After 1 day of culture, HUVECs (Figure 11(a)) and ECV304 (Figure 11(b)) on the SF-modified scaffolds show the better vitality than that on the unmodified scaffolds. After 3, 5, and 7 days of culture, there are obvious differences between two kinds of scaffolds for the cells. The SF-modified scaffolds have better biocompatibility to support the HUVECs and ECV304 growth and proliferation.
4.3.2. Cells Morphology
The morphologies of HUVEC are shown in Figure 12. After 3 days of culture, the HUVECs on SF-modified porous PHBHHx scaffold show better vitality (Figure 12(a)) than that on unmodified scaffold (Figure 12(b)), and then, after 5 days of culture, continuous cell monolayer is formed on modified scaffold (Figure 12(c)), which cannot be formed on the unmodified one (Figure 12(d)).
The ECV304 cells on the SF-modified PHBHHx scaffolds form a continuous monolayer with closer connection (Figure 13(a)) than those on the PHBHHx scaffold (Figure 13(b)) after 7 days of culture. Moreover, the cells grew more evenly on the SF-modified PHBHHx porous scaffolds and spread with close space between each other. Figure 13(c) shows an amplified single cell image where the cell grows well and stretches out into the pores of the PHBHHx scaffold after 7 days of culture. The pseudopodium and microvillus are clearly observed in the image. It indicates that there is a proper environment for the cells growth on the SF-modified PHBHHx scaffold.
4.3.3. Extracellular Matrix Secretion from HUVECs
Extracellular matrix (ECM) is the secretion of the cells during the growth and proliferation of the cells in vitro and in vivo. The collagen is one of the important components in the ECM. The secretion function of the cells cultured on the scaffolds can be evaluated by the content of the collagen. The trend of the collagen secretion from the HUVECs cultured on the porous scaffold within 5 to 15 days is shown in Figure 14. We find that the collagen content on the SF-modified scaffold is significantly higher than that on the unmodified scaffold. The conclusion can be made that SF modification benefits the ECM secretion of the cells and the formation of the cell network in the porous scaffolds.
To achieve an ideal biodegradable polymer implant with less inflammation reactions, antithrombin, and proper hydrophilic surface for the clinical applications, a natural protein, silk fibroin, which possesses excellent biocompatibility, is utilized as a modificator to treat the PHBHHx porous scaffolds. The mechanical tests show that the surface modification by 0.75 wt% concentration of the silk fibroin does not affect the mechanical property of PHBHHx material and meets the requirement of the cardiovascular tissue engineering. The result of water diffusion in the PHBHHx (HHx = 12 mol%) indicates that the higher water diffusion coefficient of PHBHHx than that of PHB implies that the PHBHHx is more biocompatible, especially for the transportation of water and the soluble nutrition into the cells through the polymer scaffold. ATR-FTIR results prove that the silk fibroin can adhere on the PHBHHx surface firmly, even flushed by the PBS for 21 days. Three types of cardiovascular-related cells, such as human fibroblasts, smooth muscle cells, human umbilical vascular endothelial cells, and endothelial-like cell line-ECV304, were cultured on the SF-modified PHBHHx porous scaffolds demonstrating that SF-modified PHBHHx porous scaffolds have a better cell adhesion and proliferation than PHBHHx. As a result, SF-modified PHBHHx porous scaffolds have potential application into the tissue-engineered cardiovascular materials.
This project was supported by the Natural Science Foundation of China (nos. 10475017, 20673022, 21074025).
- I. Vesely, “Heart valve tissue engineering,” Circulation Research, vol. 97, no. 8, pp. 743–755, 2005.
- R. Langer and J. P. Vacanti, “Tissue engineering,” Science, vol. 260, no. 5110, pp. 920–926, 1993.
- S. Y. Lee, “Bacterial polyhydroxyalkanoates,” Biotechnology and Bioengineering, vol. 49, no. 1, pp. 1–14, 1996.
- X. Hu, H. Shen, F. Yang, J. Bei, and S. Wang, “Preparation and cell affinity of microtubular orientation-structured PLGA(70/30) blood vessel scaffold,” Biomaterials, vol. 29, no. 21, pp. 3128–3136, 2008.
- P. Sangsanoh, S. Waleetorncheepsawat, O. Suwantong et al., “In vitro biocompatability of Schwann cells on surfaces of biocompatible polymeric electrospun fibrous and solution-cast film scaffolds,” Biomacromolecules, vol. 8, no. 5, pp. 1587–1594, 2007.
- N. Mei, G. Chen, P. Zhou et al., “Biocompatibility of poly(ε-caprolactone) scaffold modified by chitosan—the fibroblasts proliferation in vitro,” Journal of Biomaterials Applications, vol. 19, no. 4, pp. 323–339, 2005.
- G. Q. Chen and Q. Wu, “The application of polyhydroxyalkanoates as tissue engineering materials,” Biomaterials, vol. 26, no. 33, pp. 6565–6578, 2005.
- S. Cheng, Q. Wu, F. Yang, M. Xu, M. Leski, and G. Q. Chen, “Influence of DL-β-hydroxybutyric acid on cell proliferation and calcium influx,” Biomacromolecules, vol. 6, no. 2, pp. 593–597, 2005.
- Y. Doi, S. Kitamura, and H. Abe, “Microbial synthesis and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate),” Macromolecules, vol. 28, no. 14, pp. 4822–4828, 1995.
- K. Zhao, Y. Deng, J. C. Chen, and G. Q. Chen, “Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility,” Biomaterials, vol. 24, no. 6, pp. 1041–1045, 2003.
- R. Sodian, S. P. Hoerstrup, J. S. Sperling et al., “Early in vivo experience with tissue-engineered trileaflet heart valves,” Circulation, vol. 102, no. 19, pp. III22–III29, 2000.
- Y. W. Wang, Q. Wu, and G. Q. Chen, “Attachment, proliferation and differentiation of osteoblasts on random biopolyester poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds,” Biomaterials, vol. 25, no. 4, pp. 669–675, 2004.
- X. H. Qu, Q. Wu, K. Y. Zhang, and G. Q. Chen, “In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: biodegradation and tissue reactions,” Biomaterials, vol. 27, no. 19, pp. 3540–3548, 2006.
- M. H. Ho, D. M. Wang, L. T. Hou, C. Y. Tu, H. J. Hsieh, and J. Y. Lai, “RGD immobilization on PLLA membranes to promote biocompatibility,” Desalination, vol. 200, no. 1–3, pp. 501–502, 2006.
- Y. Wang, H. J. Kim, G. Vunjak-Novakovic, and D. L. Kaplan, “Stem cell-based tissue engineering with silk biomaterials,” Biomaterials, vol. 27, no. 36, pp. 6064–6082, 2006.
- B. Panilaitis, G. H. Altman, J. Chen, H. J. Jin, V. Karageorgiou, and D. L. Kaplan, “Macrophage responses to silk,” Biomaterials, vol. 24, no. 18, pp. 3079–3085, 2003.
- G. Chen, P. Zhou, N. Mei et al., “Silk fibroin modified porous poly(ε-caprolactone) scaffold for human fibroblast culture in vitro,” Journal of Materials Science: Materials in Medicine, vol. 15, no. 6, pp. 671–677, 2004.
- G. Chen, P. Zhou, L. F. Pan et al., “Growth of human fetal lung fibroblasts on the natural biomaterial-chitosan scaffold,” Acta Chimica Sinica, vol. 62, no. 10, pp. 992–997, 2004.
- N. Mei, P. Zhou, L. F. Pan et al., “Biocompatibility of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) modified by silk fibroin,” Journal of Materials Science: Materials in Medicine, vol. 17, no. 8, pp. 749–758, 2006.
- M. Sun, L. F. Pan, S. Liu, and H. X. Yang, “Enhanced cell affinity of the silk fibroin modified PHBHHx material,” Journal of Materials Science: Materials in Medicine, vol. 20, no. 8, pp. 1743–1751, 2009.
- H. X. Yang, M. Sun, and P. Zhou, “Investigation of water diffusion in poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) by generalized two-dimensional correlation ATR-FTIR spectroscopy,” Polymer, vol. 50, no. 6, pp. 1533–1540, 2009.
- A. L. Iordanskii and P. P. Kamaev, “The effect of preparation procedure on water sorption in membranes based on bacterial poly(3-hydroxybutyrate),” Vysokomolekularnye Soedineniya A&B, vol. 41, no. 2, pp. 374–378, 1999.
- A. L. Iordanskii, P. P. Kamaev, and G. E. Zaikov, “Water sorption and diffusion in poly-(3-hydroxybutyrate) films,” Polymer-Plastics Technology and Engineering, vol. 38, no. 4, pp. 729–738, 1999.
- K. Cai, K. Yao, Y. Cui et al., “Influence of different surface modification treatments on poly(D,L-lactic acid) with silk fibroin and their effects on the culture of osteoblast in vitro,” Biomaterials, vol. 23, no. 7, pp. 1603–1611, 2002.
- Y. Zhang, P. Zhou, L. F. Pan, S. Z. Xie, M. Sun, and W. T. Li, “Growth of human smooth muscle cells on the silk fibroin modified-polyhydroxyalkanoate scaffold,” Acta Chimica Sinica, vol. 65, pp. 2935–2940, 2007.
- A. Padermshoke, H. Sato, Y. Katsumoto, S. Ekgasit, I. Noda, and Y. Ozaki, “Crystallization behavior of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) studied by 2D IR correlation spectroscopy,” Polymer, vol. 45, no. 21, pp. 7159–7165, 2004.
- Y. W. Wang, Q. Wu, and G. Q. Chen, “Reduced mouse fibroblast cell growth by increased hydrophilicity of microbial polyhydroxyalkanoates via hyaluronan coating,” Biomaterials, vol. 24, no. 25, pp. 4621–4629, 2003.
- M. Sun, H. X. Yang, P. Zhou, L. F. Pan, and S. Liu, “Biocompatibility of PHBHHx and silk fibroin-modified PHBHHx scaffolds with human umbilical vein endothelial cells,” Acta Polymerica Sinica, vol. 0, no. 6, pp. 1430–1436, 2010.
Copyright © 2011 Hua-Xiao Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.